These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

708 related articles for article (PubMed ID: 32863938)

  • 1. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
    Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
    Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
    [No Abstract]   [Full Text] [Related]  

  • 2. RNF106 aggravates esophageal squamous cell carcinoma progression through LATS2/YAP axis.
    Sun Q; Lu H; Zhang W; Du Y; Liang Q; Zhang Y; Wu J; Zhong M
    Arch Biochem Biophys; 2023 Jul; 742():109640. PubMed ID: 37207933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling.
    Liu Y; Su P; Zhao W; Li X; Yang X; Fan J; Yang H; Yan C; Mao L; Ding Y; Zhu J; Niu Z; Zhuang T
    Cancer Sci; 2021 Jul; 112(7):2714-2727. PubMed ID: 33939216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YAP/TEAD4-induced KIF4A contributes to the progression and worse prognosis of esophageal squamous cell carcinoma.
    Li Y; Zhu X; Yang M; Wang Y; Li J; Fang J; Guo W; Ma S; Guan F
    Mol Carcinog; 2021 Jul; 60(7):440-454. PubMed ID: 34003522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CircPDE5A-encoded novel regulator of the PI3K/AKT pathway inhibits esophageal squamous cell carcinoma progression by promoting USP14-mediated de-ubiquitination of PIK3IP1.
    Lei K; Liang R; Liang J; Lu N; Huang J; Xu K; Tan B; Wang K; Liang Y; Wang W; Lin H; Wang M
    J Exp Clin Cancer Res; 2024 Apr; 43(1):124. PubMed ID: 38658954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IKBIP promotes tumor development via the akt signaling pathway in esophageal squamous cell carcinoma.
    Hu J; Dai C; Ding Z; Pan Y; Lu L; Bao J; Zheng J
    BMC Cancer; 2024 Jun; 24(1):759. PubMed ID: 38914958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleoporin 93, a new substrate of the E3 ubiquitin protein ligase HECTD1, promotes esophageal squamous cell carcinoma progression.
    Zhang J; Xin Y; Ling X; Liang H; Zhang L; Fang C; Ma J
    Hum Cell; 2024 Jan; 37(1):245-257. PubMed ID: 37993750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFI6 depletion inhibits esophageal squamous cell carcinoma progression through reactive oxygen species accumulation via mitochondrial dysfunction and endoplasmic reticulum stress.
    Liu Z; Gu S; Lu T; Wu K; Li L; Dong C; Zhou Y
    J Exp Clin Cancer Res; 2020 Jul; 39(1):144. PubMed ID: 32727517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLC34A2 promotes cell proliferation by activating STX17-mediated autophagy in esophageal squamous cell carcinoma.
    Xu Y; Duan S; Ye W; Zheng Z; Zhang J; Gao Y; Ye S
    Thorac Cancer; 2024 Jun; 15(17):1369-1384. PubMed ID: 38720472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E2F1-activated NRSN2 promotes esophageal squamous cell carcinoma progression through AKT/mTOR pathway.
    Yan Z; Xu T; Lu J; Wu Z; Li X; Xu J; Guo W; Dong Z
    Pathol Res Pract; 2022 Aug; 236():153963. PubMed ID: 35662041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA MALAT1/miR-181a-5p affects the proliferation and adhesion of myeloma cells via regulation of Hippo-YAP signaling pathway.
    Sun Y; Jiang T; Jia Y; Zou J; Wang X; Gu W
    Cell Cycle; 2019 Oct; 18(19):2509-2523. PubMed ID: 31397203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hippo-YAP signaling pathway drives CD24-mediated immune evasion in esophageal squamous cell carcinoma via macrophage phagocytosis.
    Zhou X; Yan Z; Hou J; Zhang L; Chen Z; Gao C; Ahmad NH; Guo M; Wang W; Han T; Chang T; Kang X; Wang L; Liang Y; Li X
    Oncogene; 2024 Feb; 43(7):495-510. PubMed ID: 38168654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The RNF214-TEAD-YAP signaling axis promotes hepatocellular carcinoma progression via TEAD ubiquitylation.
    Lin M; Zheng X; Yan J; Huang F; Chen Y; Ding R; Wan J; Zhang L; Wang C; Pan J; Cao X; Fu K; Lou Y; Feng XH; Ji J; Zhao B; Lan F; Shen L; He X; Qiu Y; Jin J
    Nat Commun; 2024 Jun; 15(1):4995. PubMed ID: 38862474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Cell-Derived Complement Component C1r Acts as a Prognostic Biomarker and Promotes Esophageal Squamous Cell Carcinoma Progression.
    Tang M; Zhao S; Ren L; Li Q; Li L; Wang C; Meng C; Chen Y; Hu W
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):138. PubMed ID: 38682192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PHF5A promotes esophageal squamous cell carcinoma progression via stabilizing VEGFA.
    Chang Z; Jia Y; Gao M; Song L; Zhang W; Zhao R; Yu D; Liu X; Li J; Qin Y
    Biol Direct; 2024 Mar; 19(1):19. PubMed ID: 38429756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NUPR1 induces autophagy and promotes the progression of Esophageal squamous cell carcinoma via the MAPK-mTOR pathway.
    Ren S; Chen Y; Wang Q; Song L; Xin Z; Shi M; Liu X
    Pathol Res Pract; 2024 May; 257():155323. PubMed ID: 38653091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional inhibition by CDK7/9 inhibitor SNS-032 suppresses tumor growth and metastasis in esophageal squamous cell carcinoma.
    Zeng H; Yang H; Song Y; Fang D; Chen L; Zhao Z; Wang C; Xie S
    Cell Death Dis; 2021 Nov; 12(11):1048. PubMed ID: 34741018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA GK-IT1 promotes esophageal squamous cell carcinoma by regulating MAPK1 phosphorylation.
    Yang X; Zeng T; Liu Z; He W; Hu M; Tang T; Chen L; Xing L
    Cancer Med; 2022 Dec; 11(23):4555-4574. PubMed ID: 35608100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low expression of PINK1 and PARK2 predicts poor prognosis in patients with esophageal squamous cell carcinoma.
    Lu X; Yao Y; Ma Y; Zhang X; Peng H; Pei Y; Lu Y; Wang L
    World J Surg Oncol; 2023 Oct; 21(1):321. PubMed ID: 37833780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-624-mediated ARRDC3/YAP/HIF1α axis enhances esophageal squamous cell carcinoma cell resistance to cisplatin and paclitaxel.
    Yan J; Shi L; Lin S; Li Y
    Bioengineered; 2021 Dec; 12(1):5334-5347. PubMed ID: 34415232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.